Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicit...

par Vinjamuri, S, Gilbert, T M, Banks, M, McKane, G, Maltby, P, Poston, G, Weissman, H, Palmer, D H, Vora, J, Pritchard, D M, Cuthbertson, D J
Publié 2013

Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training

par Sprung, V S, Cuthbertson, D J, Pugh, C J A, Daousi, C, Atkinson, G, Aziz, N F, Kemp, G J, Green, D J, Cable, N T, Jones, H
Publié 2013

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality

par Dobson, R, Burgess, M I, Valle, J W, Pritchard, D M, Vora, J, Wong, C, Chadwick, C, Keevi, B, Adaway, J, Hofmann, U, Poston, G J, Cuthbertson, D J
Publié dans Br J Cancer (2014)